4//SEC Filing
Schindel Yair Chaim 4
Accession 0000899243-20-025654
CIK 0001720580other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 9:55 PM ET
Size
8.4 KB
Accession
0000899243-20-025654
Insider Transaction Report
Form 4
Adicet Bio, Inc.ACET
Schindel Yair Chaim
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2020-09-17+30,000→ 30,000 totalExercise: $16.11Exp: 2030-09-16→ Common Stock (30,000 underlying) - Award
Common Stock
2020-09-15+1,104,460→ 1,104,460 total(indirect: By Partnership)
Footnotes (3)
- [F1]The reporting person is the sole shareholder of aMoon General Partner Ltd., which is the sole general partner of aMoon 2 Fund G.P. Limited Partnership, which is the sole general partner of aMoon 2 Fund Limited Partnership, which directly holds the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F2]Received in exchange for shares of Series B Preferred Stock of Adicet Bio, Inc., a Delaware corporation ("Old Adicet"), in connection with the merger (the "Merger") of Old Adicet with and into Project Oasis Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of resTORbio, Inc., a Delaware corporation ("resTORbio"). On the effective date of the Merger, the closing share price of a share of resTORbio common stock was $2.28 per share. On the effective date of the Merger, resTorbio changed its name to "Adicet Bio, Inc."
- [F3]The shares of common stock subject to the option shall vest in equal installments on each of the thirty-six (36) monthly anniversaries of the vesting commencement date, provided that the reporting person remains in continuous service as of the applicable vesting date.
Documents
Issuer
Adicet Bio, Inc.
CIK 0001720580
Entity typeother
Related Parties
1- filerCIK 0001823758
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 9:55 PM ET
- Size
- 8.4 KB